zb

Zimmer Biomet

ZBH
NYSE
$90.95

Does Zimmer Biomet have a strong competitive moat?

Zimmer Biomet shows a solid competitive position with solid gross margins of 70.8%. However, returns on capital that fall short of elite levels suggests the moat, while present, may face challenges. The business earns above-average returns but lacks the exceptional durability of the strongest moats.